BIM
ELGX

Bogle Investment Management’s Endologix Inc ELGX Stock Holding History

Bogle Investment Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,630
Closed -$387K – 523
2016
Q1 		$387K Buy
+4,630
New +$382K 0.03% 349

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bogle Investment Management's ELGX Position: Q2 2016 in Review

Bogle Investment Management sold out of Endologix Inc (ELGX) in Q2 2016, closing a stake of 4,630 shares — an estimated $387K sold.

Bogle Investment Management first reported a position in ELGX in Q1 2016 and held it in 1 quarter. The position peaked at $387K in Q1 2016. 163 funds tracked by Wall St. Rank hold ELGX as of Q2 2016.

  • Bogle Investment Management reported no remaining Endologix Inc position as of Q2 2016 after selling out during the quarter.
  • Bogle Investment Management sold 4,630 Endologix Inc shares in Q2 2016, an estimated $387K.
  • Bogle Investment Management first reported a position in Endologix Inc in Q1 2016 and held it in 1 quarter.
  • Bogle Investment Management's Endologix Inc position peaked at $387K in Q1 2016.
  • 163 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2016.

Based on Bogle Investment Management's 13F filing for Q2 2016, filed 12 Aug 2016.